EC knowledge among women of reproductive age: 11.6% (DHS 2010)
Contraceptive Use: 14.3% (DHS 2010, ever use of any modern method among women of reproductive age)
Registered LNG-EC products:
- NorLevo 1.5mg* - Available directly from pharmacist without prescription (i.e. BTC)
- Optinor - Available only from family planning clinics (applies to Optinor in most countries)
- Vikela* - Available directly from pharmacist without prescription (i.e. BTC)
Registered UPA-EC products:
- ellaOne* - Available only with prescription
Products marked with * have been approved by a stringent regulatory authority, such as the WHO Prequalification Programme, the US Food and Drug Administration, the European Medicines Agency, or other.
Where at least one type of ECP is available: Private clinics, Pharmacies, IPPF-affiliated system, Social marketing programs (eg PSI, DKT, MSI and PSIA)
Age restrictions for accessing ECPs: No data available
Legal/regulatory documents in which EC is included: Essential Medicines List
Pricing information: LNG Products: $7.45 (3,625 CFA), as of January, 2014.
Other relevant information: EC distributed via IPPF outlets (1,000 - 5,000 in 2012).
In Burkina Faso, the lowest cadre of health workers allowed to sell/dispense ECPs in the private sector is midwives, as of 2013. (USAID/DELIVER, Contraceptive Security Indicators, 2013)
In 2013, EC was not procured by the government (JSI/Deliver data).